HOOKIPA Pharma Q4 EPS $(0.22) Misses $(0.19) Estimate, Sales $7.41M Beat $4.55M Estimate, Cash Balance of $117.5M
Portfolio Pulse from Benzinga Newsdesk
HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 earnings with a per-share loss of $(0.22), missing the $(0.19) estimate, and sales of $7.41M, surpassing the $4.55M estimate. The company's cash balance stands at $117.5M.
March 22, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HOOKIPA Pharma reported a larger than expected Q4 per-share loss of $(0.22) but exceeded sales forecasts with $7.41M. The company's cash balance is $117.5M.
The mixed earnings report shows a miss on EPS but a beat on revenue estimates, which could lead to neutral market sentiment in the short term. The substantial cash balance suggests financial stability, potentially offsetting concerns about the earnings miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100